NEOG
$87.06
Neogen Cp
$1.19
1.39%
NEOG
Earnings Whisper ®
N/A
3rd Quarter February 2021
Consensus:  $0.29
Revenue:  $107.35 Mil
Tuesday
Mar 23
8:45 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Tuesday, December 22, 2020

What do you expect when NEOG reports earnings?
Beat
Meet
Miss

Where is NEOG's stock price going from here?
Up
Flat
Down
Stock chart of NEOG
Analysts
Summary of analysts' recommendations for NEOG
Score
Grade
Pivots
Resistance
$87.93
$87.15
$86.51

$85.73

Support
$85.09
$84.31
$83.67
Tweet
Growth
Description
Neogen Corporation develops, manufactures and markets a diverse line of products dedicated to food and animal safety. The Company's Lansing, Mich.-based Food Safety Division develops and markets dehydrated culture media, and rapid diagnostic test kits to detect foodborne bacteria, spoilage organisms, mycotoxins, food allergens, genetic modifications, drug residues, plant diseases, and sanitation concerns. Neogen's is the leading global provider of DNA testing for animal agribusiness and veterinary medicine. Neogen understands that its customers face serious consequences if their products are contaminated with any of a number of well-established or emerging threats, including dangerous bacteria, natural toxins, veterinary drug residues, unlabeled food allergens, rodent filth, sanitation concerns, broken veterinary needles or other contaminants.
Peers
InterCeptRegeneron PharmaceuticalsVertex PharmaceuticalsBioMarin PharmaceuticalZoetisBristol-Myers SquibbPfizerMerck & Co.Eli LillyJohnson & Johnson